Recombinant zoster vaccine offers better value, protection against shingles

Disclosure: This site contains some affiliate links. We might receive a small commission at no additional cost to you.

February 18, Vaccination with the recombinant zoster vaccine demonstrated higher cost-effectiveness and prevention of herpes zoster, compared with live zoster vaccine and no vaccination, according to research published in Annals of Internal Medicine .

Read the source article at Healio

author avatar
Jose Rossello, MD, PhD, MHCM
Leave a Comment

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}